| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 15 | -465K | 100% | $86.65 | -$40.3M |
| Net | -15 | -465K | -100% | -$40.3M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Meridian Venture Partners II Lp | 10%+ Owner | $103M | Aug 16, 2023 | ||
| Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS, Director | $45.3M | -$17.9M | -28.3% | Aug 20, 2025 |
| Nikhil Lalwani | PRESIDENT & CEO, Director | $39.3M | -$4.89M | -11.1% | Aug 12, 2025 |
| Chad Gassert | Svp Corp. Dev. & Strategy | $20.7M | -$3.05M | -12.9% | Nov 12, 2025 |
| Stephen P. Carey | Svp & Cfo | $15.6M | -$4.72M | -23.3% | Aug 12, 2025 |
| James G. Marken | Svp Ops & Prod Dev | $7.98M | Jun 7, 2024 | ||
| Ori Gutwerg | Svp, Generics | $7.69M | -$884K | -10.3% | Aug 12, 2025 |
| Christopher Mutz | Head Of Rare Disease | $6.49M | -$242K | -3.59% | May 14, 2025 |
| Meredith Cook | Sr. Vp, General Counsel & Sec. | $6.16M | -$352K | -5.41% | Dec 12, 2025 |
| Krista Davis | Svp, Chief Hr Officer | $5.9M | -$501K | -7.83% | Sep 19, 2025 |
| Patrick D. Walsh | Director | $5.37M | -$1.55M | -22.4% | Nov 13, 2025 |
| Thomas Rowland | Svp, Head Established Brands | $3.5M | -$426K | -10.9% | Aug 12, 2025 |
| Thomas Haughey | Director | $3.14M | -$1.66M | -34.6% | Aug 12, 2025 |
| Robert E. Brown JR | Director | $2.77M | Apr 27, 2022 | ||
| David Nash | Director | $2.18M | May 23, 2023 | ||
| Antonio R. Pera | Director | $2.15M | -$1.18M | -35.4% | Sep 3, 2025 |
| Jeanne Thoma | Director | $2.08M | -$1.92M | -48% | Aug 18, 2025 |
| Renee P. Tannenbaum | Director | $2.04M | -$146K | -6.68% | Dec 5, 2025 |
| Matthew J. Leonard | Director | $622K | -$841K | -57.5% | Aug 25, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|